Correlation Between Viridian Therapeutics and Coloplast

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Coloplast at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Coloplast into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Coloplast AS, you can compare the effects of market volatilities on Viridian Therapeutics and Coloplast and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Coloplast. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Coloplast.

Diversification Opportunities for Viridian Therapeutics and Coloplast

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Viridian and Coloplast is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Coloplast AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coloplast AS and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Coloplast. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coloplast AS has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Coloplast go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Coloplast

Assuming the 90 days trading horizon Viridian Therapeutics is expected to under-perform the Coloplast. In addition to that, Viridian Therapeutics is 2.12 times more volatile than Coloplast AS. It trades about -0.02 of its total potential returns per unit of risk. Coloplast AS is currently generating about 0.02 per unit of volatility. If you would invest  90,080  in Coloplast AS on August 30, 2024 and sell it today you would earn a total of  350.00  from holding Coloplast AS or generate 0.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Viridian Therapeutics  vs.  Coloplast AS

 Performance 
       Timeline  
Viridian Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Viridian Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Viridian Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Coloplast AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Coloplast AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Coloplast is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Viridian Therapeutics and Coloplast Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viridian Therapeutics and Coloplast

The main advantage of trading using opposite Viridian Therapeutics and Coloplast positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Coloplast can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coloplast will offset losses from the drop in Coloplast's long position.
The idea behind Viridian Therapeutics and Coloplast AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities